Prescription drug prices are substantially higher in the United States than in other high-income countries, and as a result, Americans spend more on prescription drugs than residents of other countries. Despite this, the government is not allowed to use its position as the largest purchaser of prescription drugs in the country to bargain for lower prices for patients.
Rep. Lloyd Doggett (D-TX) has introduced the Medicare Negotiation and Competitive Licensing Act (H.R. 1046) to give Medicare the power it needs to effectively negotiate with drug companies and bring drug prices down. Read more here.
Every representative should co-sponsor H.R. 1046, the Medicare Negotiation and Competitive Licensing Act! You can check here to see if your member of Congress (MoC) has already signed on.
Call your MoC and tell them: reject bills that would use arbitration to bring down drug prices, and co-sponsor H.R. 1046, the Medicare Negotiation and Competitive Licensing Act!